Bright Minds Biosciences (TSE:DRUG) has released an update. Bright Minds Biosciences is teaming up again with Firefly Neuroscience to analyze ...

Bright Minds Biosciences (DRUG) announced that it is once again collaborating with Firefly Neuroscience (AIFF), an Artificial Intelligence ...

Bright Minds Biosciences Inc (NASDAQ:DRUG) shares are trading higher again after soaring last week. The company on Monday ...

Bright Minds Biosciences is working with Firefly Neuroscience, an AI healthcare company, to provide a full analysis of the electroencephalogram data in Bright Minds' Phase 2 clinical trial evaluating ...

Firefly Neuroscience partners with Bright Minds Biosciences to analyze positive Phase 1 data of BMB-101 using advanced AI ...

As Firefly Neuroscience, Inc. (NASDAQ:AIFF) advances its AI-driven Brain Network Analytics technology and collaborates with Bright Minds Biosciences, investors should be aware of some key ...

VANCOUVER, British Columbia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) is pleased to announce a non ...

NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug ...

NEW YORK - Bright Minds Biosciences Inc. (NASDAQ ... preclinical results for BMB-201 were presented at the Society for Neuroscience's annual meeting at the NIH Satellite Forum, with the poster ...

TORONTO - Firefly Neuroscience, Inc. (NASDAQ:AIFF), a company specializing in artificial intelligence (AI) solutions for neurological and mental disorders, announced a collaboration with Bright Minds ...